Cancer Center

Cancer Center

Phone Numbers

Hematology / Oncology
(803) 794-7511
Radiation Oncology
(803) 791-2575
Women's Imaging
(803) 791-2486

Prostate Cancer

Our Prostate Cancer Program

  • Less-invasive scanning procedures.
  • Monthly support group for patients and their loved ones.
  • 219 cases treated in 2014.

Treating Prostate Cancer

Because prostate cancer has a low mortality rate, many men who are diagnosed don't require treatment. Those who do need treatment most often undergo radiation. Your doctor will discuss options with you and decide what's best for your individual diagnosis.

Other Possible Treatments

 

  Terence N. Chapman, MD

Terence N. Chapman, MD Lexington Urology

Most experienced urologic robotic surgeon in the Midlands

Dr. Chapman has extensive training in the diagnosis and treatment of urologic cancer, including expertise in laparoscopic kidney surgery and robotic prostatectomy using the da Vinci Robot.

He serves as director of Urologic Oncology and is a board-certified physician at Lexington Urology providing comprehensive urologic care and advanced treatments for urologic conditions, including robotic and minimally invasive surgery. Learn More >>

Nurse Navigators

A nurse navigator will work with you through the whole treatment process. She'll help you understand your diagnosis, take care of scheduling, and coordinate with doctors to get you the answers and help you need.

Supportive Care

Our care is comprehensive, with support for your personal challenges that goes beyond the disease.

Just a few ways we help:

New Treatments

Our affiliation with the MUSC Hollings Cancer Center gives patients access to more than 200 clinical trials and a wide range of the most promising cancer treatments currently available.

External Prostate Scans
Traditional scans require an imaging coil inside the body, but our new MR scan is all external, making the procedure much more comfortable for patients.

Research Trials

We offer qualifying patients access to the latest clinical trials.

Enroll in a Clinical Trial

(803) 935-8300

S2312

Description
S2312 A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCrPC), Stratified by Aggressive Variant Signature.

 This trial is testing whether the addition of carboplatin chemotherapy to cabazitaxel chemotherapy with improve outcomes compared to cabazitaxel alone in people with castrate-resistant prostate cancer that has spread beyond the prostate to other parts of the body.

Open to enrollment.

Posted By: Dr. Scott Graupner

Posted Date: 4/29/2025

Location: Lexington Medical Cancer Center

BRAT

Description
The purpose of the Prostate BRAchyTherapy (BRAT) Registry is to measure clinical outcomes of patients treated with Brachytherapy at Lexington Medical Center (LMC).

Open to enrollment

Posted By: Dr. Quillin Davis

Posted Date: 11/1/2021

Location: Lexington Medical Cancer Center

EA8184

Description
To Evaluate if Green Tea can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring.

This study is being done to answer the following question:  Can we lower the chance of your prostate cancer growing by adding Sunphenon® 90D (containing green tea catechins) by closely monitoring your prostate cancer?

Open to enrollment

Posted By: Dr. T. Brian Willard

Posted Date: 11/1/2021

Location: Lexington Urology